Phase I/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus Erythematosus
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy-Beike (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Therapeutic Use
- 01 May 2013 New trial record